BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 23266722)

  • 1. Non-melanoma skin cancer in mouse and man.
    Schwarz M; Münzel PA; Braeuning A
    Arch Toxicol; 2013 May; 87(5):783-98. PubMed ID: 23266722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
    Owens DM; Spalding JW; Tennant RW; Smart RC
    Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide.
    Mancuso M; Pazzaglia S; Tanori M; Rebessi S; Di Majo V; Covelli V; Saran A
    Mutat Res; 2004 Apr; 548(1-2):35-45. PubMed ID: 15063134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that mirex promotes a unique population of epidermal cells that cannot be distinguished by their mutant Ha-ras genotype.
    Kim TW; Porter KL; Foley JF; Maronpot RR; Smart RC
    Mol Carcinog; 1997 Sep; 20(1):115-24. PubMed ID: 9328442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation of the O6-methylguanine-DNA methyltransferase promoter suppresses expression in mouse skin tumors and varies with the tumor induction protocol.
    Abdel-Fattah R; Glick A; Rehman I; Maiberger P; Hennings H
    Int J Cancer; 2006 Feb; 118(3):527-31. PubMed ID: 16094607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression.
    Allen SM; Florell SR; Hanks AN; Alexander A; Diedrich MJ; Altieri DC; Grossman D
    Cancer Res; 2003 Feb; 63(3):567-72. PubMed ID: 12566297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mouse epidermis coexpressing transforming growth factor-alpha and v-fos: acceleration of autonomous papilloma formation and malignant conversion via c-Ha-ras activation.
    Wang XJ; Liefer KM; Greenhalgh DA; Roop DR
    Mol Carcinog; 1999 Dec; 26(4):305-11. PubMed ID: 10569807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of c-Ha-ras gene mutations in skin tumors induced in carcinogenesis-susceptible and carcinogenesis-resistant mice by different two-stage protocols or tumor promoter alone.
    Pazzaglia S; Mancuso M; Primerano B; Rebessi S; Biozzi G; Covelli V; Saran A
    Mol Carcinog; 2001 Feb; 30(2):111-8. PubMed ID: 11241758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
    Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J
    Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
    Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
    Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation of sensitivities to tumor promotion and progression in outbred and inbred SENCAR mice.
    Gimenez-Conti IB; Bianchi AB; Fischer SM; Reiners JJ; Conti CJ; Slaga TJ
    Cancer Res; 1992 Jun; 52(12):3432-5. PubMed ID: 1375869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of gene expression with sequential proliferation, differentiation and tumor formation in murine skin.
    Ridd K; Zhang SD; Edwards RE; Davies R; Greaves P; Wolfreys A; Smith AG; Gant TW
    Carcinogenesis; 2006 Aug; 27(8):1556-66. PubMed ID: 16537558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Squamous cell hyperplastic foci: precursors of cutaneous papillomas induced in SENCAR mice by a two-stage carcinogenesis regimen.
    Binder RL; Johnson GR; Gallagher PM; Stockman SL; Sundberg JP; Conti CJ
    Cancer Res; 1998 Oct; 58(19):4314-23. PubMed ID: 9766659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent codon 12 Ki-ras mutations in mouse skin tumors initiated by N-methyl-N'-nitro-N-nitrosoguanidine and promoted by mezerein.
    Rehman I; Lowry DT; Adams C; Abdel-Fattah R; Holly A; Yuspa SH; Hennings H
    Mol Carcinog; 2000 Apr; 27(4):298-307. PubMed ID: 10747294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced sensitivity to tumor growth and development in multistage skin carcinogenesis by transforming growth factor-alpha-induced epidermal growth factor receptor activation but not p53 inactivation.
    Shibata MA; Ward JM; Green JE; Merlino G
    Mol Carcinog; 1997 Mar; 18(3):160-70. PubMed ID: 9115586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [p53 gene mutations in mouse skin tumors induced by DMBA-TPA-MNNG].
    Zhang S; Guo ; Klein-Szanto A
    Zhonghua Bing Li Xue Za Zhi; 1998 Aug; 27(4):298-300. PubMed ID: 11245002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multihit, multistage model of chemical carcinogenesis.
    Owens DM; Wei S; Smart RC
    Carcinogenesis; 1999 Sep; 20(9):1837-44. PubMed ID: 10469632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of oral versus topical administration of cyclosporine on phorbol ester promotion of murine epidermal carcinogenesis.
    Yokota K; Gill TJ; Shinozuka H
    Cancer Res; 1989 Aug; 49(16):4586-90. PubMed ID: 2501029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metallothionein deficiency enhances skin carcinogenesis induced by 7,12-dimethylbenz[a]anthracene and 12-O-tetradecanoylphorbol-13-acetate in metallothionein-null mice.
    Suzuki JS; Nishimura N; Zhang B; Nakatsuru Y; Kobayashi S; Satoh M; Tohyama C
    Carcinogenesis; 2003 Jun; 24(6):1123-32. PubMed ID: 12807749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin.
    Hennings H; Glick AB; Lowry DT; Krsmanovic LS; Sly LM; Yuspa SH
    Carcinogenesis; 1993 Nov; 14(11):2353-8. PubMed ID: 8242866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.